Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹800 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,757.0 Cr 1.3% 2.1% 29% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,982.0 Cr 0.9% 5.6% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,361.0 Cr 1.2% 3.7% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,737.0 Cr 4.4% 10.3% 42.1% Stock Analytics
CIPLA ₹115,655.0 Cr -1.7% 3.1% -4.2% Stock Analytics
DR REDDYS LABORATORIES ₹112,573.0 Cr 0.2% 5.7% 6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.3%

2.1%

29%

SENSEX

-0.5%

3%

-8.5%


You may also like the below Video Courses